| |
| |
|
| Insider
Information: |
Mahon Paul A |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,710 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,148,112 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,710 |
|
|
| Total
Value |
$10,148,112 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
|
2024-04-04 |
36,710 |
2004-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
807 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 31 of 33
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-01-19 |
4 |
AS |
$258.42 |
$1,553,683 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-02-02 |
4 |
AS |
$254.17 |
$1,527,794 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-02-02 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,397 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-02-16 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,397 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-02-16 |
4 |
AS |
$248.67 |
$1,494,922 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-03-02 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,397 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-03-02 |
4 |
AS |
$241.17 |
$1,455,418 |
D/D |
(6,000) |
36,397 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-03-16 |
4 |
AS |
$211.87 |
$1,286,342 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-03-16 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-04-06 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-04-06 |
4 |
AS |
$231.93 |
$1,396,755 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-04-20 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-04-20 |
4 |
AS |
$223.63 |
$1,343,755 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-05-04 |
4 |
AS |
$215.15 |
$1,294,903 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-05-04 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-05-18 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-05-18 |
4 |
AS |
$214.27 |
$1,287,473 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-06-01 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-06-01 |
4 |
AS |
$207.01 |
$1,254,677 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-06-15 |
4 |
AS |
$227.52 |
$1,366,634 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-06-15 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-07-06 |
4 |
OE |
$120.26 |
$721,560 |
D/D |
6,000 |
42,599 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-07-06 |
4 |
AS |
$214.58 |
$1,291,165 |
D/D |
(6,000) |
36,599 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-07-20 |
4 |
OE |
$120.26 |
$300,650 |
D/D |
2,500 |
39,099 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & GENERAL COUNSEL |
• – – |
2023-07-20 |
4 |
AS |
$243.87 |
$609,675 |
D/D |
(2,500) |
36,599 |
0 |
% |
|
807 Records found
|
|
Page 31 of 33 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
